Acute Coronary
Syndrome

CARDIOLOGY SOLUTIONS

Time to intervention can be a risk: delays to reperfusion correlate with higher rates of mortality and morbidity. Approximately 80 percent of all CVD deaths are due to heart attacks.1

The Patient Journey

PRE-HOSPITAL TRANSFER
Rapid transport, ECG monitoring and patient stabilization are critical for patients having an ST-segment elevation myocardial infarction. Nearly half of potentially salvageable myocardium is lost within one hour of the coronary artery being occluded, and nearly 2/3 lost within three hours.3 The ability to send observations and test results wirelessly can be invaluable to attending physicians and interventional lab preparations — potentially enabling fast action upon arrival to aid quality patient outcomes such as door to balloon time.4

Pre-hospital ECG
Help reduce time to balloon with data from EMS to hospital to verify diagnosis, pre-notify ER staff with wireless transfer. Every heartbeat sends a vital message, and you can't settle for just getting part of the story.


MAC™ resting ECG carts with 12SL™ Analysis
Decision support and predictive outcomes plus improved sensitivity through gender specific interpretation.


DIAGNOSIS & RISK ASSESSMENT
There are many potential causes of chest pain. For patients not sent immediately to the interventional lab for revascularization, guidelines suggest use of biomarkers, clinical history, ECG and non-invasive imaging measurement results, and other factors, to determine TIMI risk score which in turn can guide revascularization decisions.5 There are available estimates for sensitivity and specificity for the various non-invasive tests to diagnose the presence of CAD, but other factors are frequently considered such as equipment availability and patient tolerance.6

CARESCAPE™ Monitoring Portfolio
Diagnostic quality of 12SL™ analysis and initial interpretation, along with two-way integration to the MUSE™ cardiology information system for fast, validated access to patient's 12SL history & serial comparison.

ApexPro CH/FX Telemetry
Analyze ECG leads with EK-Pro algorithm to identify arrhythmias.

Revolution™ CT & CardioGraphe7
Achieve one-beat, whole heart acquisition for imaging or comprehensive cardiac assessment with or without beta blockers at any heart rate.8

Discovery™ MI
Initial risk assessment through myocardial perfusion and cardiac flow reserve., while diagnostic CT allows complementary CT cardiovascular imaging.

Vivid™ Family Cardiac Ultrasound. Automated Function Imaging (AFI)
Assess left ventricular function and cardiac performance with clarity, improving clinical confidence.

Discovery™ NM530c
Provides myocardial perfusion scans in as fast as three minutes, for the flexibility to choose between dose reduction, faster acquisitions or improved statistics.

800 Series
Provides myocardial perfusion imaging in less than half the time of traditional technology using Evolution for Cardiac and SwiftScan acquisitions, with or without the added benefit of CT-based attenuation correction and the addition of Coronary Artery Calcium Scoring.

INTERVENTION
For patients sent for revascularization in the catheterization lab, attempts are made to rapidly access the culprit artery and complete further assessment of coronary tree. Rapid intervention can help minimize time to reperfusion from first medical contact.

Innova™ IGS 5 or Discovery™ IGS 7
Helps reduce use of contrast and dose with one of the industry’s highest ratings for Detective Quantum Efficiency (DQE). 9


PCI ASSIST10
Help plan, assess and guide interventional procedures with improved visibility up to 85 percent in moving anatomy.


Mac-Lab™
Dependability, ease of use and excellent IT data integration. Mac-Lab™ Hemodynamic Recording System provides efficient information integration to help drive clinical throughput in high-speed, high-volume labs.


CARESCAPE™ Monitoring Portfolio
Diagnostic quality of 12SL™ analysis and initial interpretation, along with two-way integration to the MUSE™ cardiology information system for fast, validated access to patient’s 12SL history & serial comparison.


PATIENT FOLLOW-UP
Follow-up treatment and rehabilitation strategies typically include non-invasive monitoring of LV function and strain.

Vivid™ Family Cardiac Ultrasound
Vivid E95 with cSound performance makes 4D as easy as 2D to quantify left ventricular wall motion.


Vivid™ Family Cardiac Ultrasound - Automated Function Imaging (AFI)
Assess left ventricular function and cardiac performance with clarity, improving clinical confidence.


800 Series
Provides myocardial perfusion imaging in less than half the time of traditional technology using Evolution for Cardiac and SwiftScan acquisitions, with or without the added benefit of CT-based attenuation correction and the addition of Coronary Artery Calcium Scoring.


Discovery™ MI
Initial risk assessment through myocardial perfusion and cardiac flow reserve., while diagnostic CT allows complementary CT cardiovascular imaging.


DIGITAL FOUNDATION AND INNOVATIONS
Digital solutions, analytics and AI innovations such as GE Healthcare's Edison Platform, Muse and Centricity Cardio Enterprise connect our wing-to-wing technologies to practitioners for better cardiology outcomes, more efficiently.

MUSE™ ECG Management
By integrating with MUSE, data from home-based patients will be made available to clinicians on the same clinical workspace they use every day.


Centricity™ Cardio Enterprise2
Helps bridge the gaps between cardiovascular service lines with a single point of access.


REFERENCES